Loading...
Loading...
India's cefpodoxime imports from UNITED STATES total $865 across 2 shipments from 2 foreign suppliers. NEW LIFE MEDICALS (USA) INC leads with $855 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include FDC LIMITED. This corridor reflects India's pharmaceutical import demand for cefpodoxime — a concentrated sourcing relationship with select suppliers from UNITED STATES.

NEW LIFE MEDICALS (USA) INC is the leading Cefpodoxime supplier from UNITED STATES to India, with import value of $855 across 1 shipments. The top 5 suppliers — NEW LIFE MEDICALS (USA) INC, M/S RISING PHARMA HOLDINGS — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEW LIFE MEDICALS (USA) INC | $855 | 1 | 98.8% |
| 2 | M/S RISING PHARMA HOLDINGS | $10 | 1 | 1.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | FDC LIMITED | $855 | 1 | 98.8% |
| 2 | AUROBINDO PHARMA LTD | $10 | 1 | 1.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Cefpodoxime suppliers from UNITED STATES to India include NEW LIFE MEDICALS (USA) INC, M/S RISING PHARMA HOLDINGS. The leading supplier is NEW LIFE MEDICALS (USA) INC with import value of $855 USD across 1 shipments. India imported Cefpodoxime worth $865 USD from UNITED STATES in total across 2 shipments.
India imported Cefpodoxime worth $865 USD from UNITED STATES across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Cefpodoxime sourced from UNITED STATES include FDC LIMITED, AUROBINDO PHARMA LTD. The largest buyer is FDC LIMITED with $855 in imports across 1 shipments.
The total value of Cefpodoxime imports from UNITED STATES to India is $865 USD, across 2 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists